Back to search
FDAFDA · Food and drugs·Recall number D-613-2013

0.45% Sodium Chloride Injection, USP, Rx Only, 250 mL, by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7132-02

Published July 3, 2013 · Recall initiated: May 4, 2012

Summary

FDA records drug Class II recall D-613-2013, published July 3, 2013 and initiated May 4, 2012. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 136,584 units; Lot: Lot #: 93-153-JT, Exp 9/12. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.

What to do

Voluntary: Firm initiated · Letter

Get an email if SODIUM CHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
SODIUM CHLORIDE
Manufacturer
Hospira Inc.
Distributor
Nationwide Puerto Rico, U.S. Virgin Island, Libya, Saudi Arabia
Lot
Lot #: 93-153-JT, Exp 9/12
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 0.45% Sodium Chloride Injection, USP, Rx Only, 250 mL, by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7132-02 recalled?

Yes. FDA published recall D-613-2013 on July 3, 2013. Reported hazard: Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: SODIUM CHLORIDE.